(Q79207207)
Statements
A feasibility study of the efficacy and tolerability of the combination of Exemestane with the COX-2 inhibitor Celecoxib in post-menopausal patients with advanced breast cancer (English)
P A Canney
M A Machin
scientific article published on 05 October 2006